Medical Plastic Market Report will Reach to USD 86.99 Billion by 2029
Medical Plastic Market Size By
Product (Polyethylene, Polypropylene, Polyphenylsulfone, Liquid Crystal
Polymer, and Others), By Application (Medical Components, Medical Device
Packaging, Orthopedic Soft Goods Mobility Aids, and Others), Regions,
Segmentation, and forecast till 2029.
The market has been studied for the below-mentioned segmentation and
regional analysis for North America, Europe, Asia, South America, and Middle
East and Africa. These are the key regions where the Medical Plastic
market is operating currently and is predicted to expand in the near
future. The manufacturers and suppliers involved in the Medical Plastic
treatment market are present across various countries in the regions
mentioned above.
Get Sample Copy of This Report @
https://greyviews.com/reports/medical-plastic-market/175/request-sample
The report provides a detailed understanding of the market segments
formed by combining different prospects such as product, application, and
others. The key driving factors, restraints, potential growth opportunities,
and market challenges are also discussed in the paragraphs below.
The significant players operating in the global Medical
Plastic market are Rรถchling SE & Co. KG, Eastman
Chemical Company, Saint-Gobain Performance Plastics, Nolato AB, SABIC, Dow,
Orthoplastics Ltd, Celanese Corporation, Tekni-Plex, Trelleborg AB, Solvay
S.A., HMC Polymers, Trinseo, ARAN BIOMEDICAL TEORANTA, Avantor Inc, Evonik
Industries AG., and among others.
To achieve a substantial market share in the worldwide Medical Plastic market
and strengthen their position, manufacturers are pursuing expansion methods
such as current developments, mergers and acquisitions, product innovations,
collaborations, and partnerships, joint ventures.
Plastics made specifically for use in medical
products are referred to as medical plastics. Additionally, it is employed in
the production of in vitro diagnostic devices and main pharmaceutical
packaging, which protects and contains medications to prevent tampering. As the
global market for high-quality medical devices continues to grow, medical
plastic goods have evolved. Such devices are now an essential part of the
contemporary healthcare system. Medical plastic does not exactly have a
regulatory definition. The specifications for materials that can be used in
medical devices are laid out in ISO 10993. So long as the overall gadget
complies with those specifications, producers theoretically have the freedom to
utilize any plastic when creating medical devices. Devices made of medical
plastic come in a huge variety. Plastics are employed more and more because of
their superior performance, lightweight, and low cost in everything from test
equipment like vials and beakers to surgical instruments, catheters, and
implants. As medical plastic is shatterproof and impermeable, it is safe to
transport biohazardous chemicals in it. This promotes the safe clearance of
medical waste, which stops the transmission of harmful illnesses. Tamper-proof
caps are used even in medications to guarantee that the contents are clean and
pathogen-free. Patients who would often object to the use of traditional
materials like latex in medical devices have shown little difficulty accepting
plastic medical devices like implants. With hypoallergenic plastic, patients
are less likely to experience pain, discomfort, immune system aggravation, and
skin irritation.
Enquiry Before
Buying This Report @ https://greyviews.com/inquiry/175
Scope of Medical Plastic
Market Report
|
Report Metric |
Information |
|
Study Period |
2021-2029 |
|
Base Year |
2021 |
|
Forecast Period |
2022-2029 |
|
Market Share Unit |
USD
Billion |
|
Segments Covered |
By Product, By Application, By Region |
|
Regions Covered |
North
America, Europe, Asia-Pacific, South America and Middle-East and Africa |
|
Major Players |
Rรถchling
SE & Co. KG, Eastman Chemical Company, Saint-Gobain Performance Plastics,
Nolato AB, SABIC, Dow, Orthoplastics Ltd, Celanese Corporation, Tekni-Plex,
Trelleborg AB, Solvay S.A., HMC Polymers, Trinseo, ARAN BIOMEDICAL TEORANTA,
Avantor Inc, Evonik Industries AG., among others |
Segmentation Analysis
The polypropylene segment is expected to be the fastest-growing
segment in 2021.
The product includes polyethylene, polypropylene, polyphenylsulfone,
liquid crystal polymer, and others. During the forecast period, the
polypropylene segment is anticipated to grow at the fastest rate. Due to its
exceptional resilience, polypropylene is utilized to make protective packaging
and medical equipment. Additionally, due to its strong chemical bonding, it can
be used to manufacture a variety of medical products, including test tubes,
connectors, reusable plastic containers, pharmacy prescription bottles,
disposable syringes, and non-absorbable sutures. Additionally, polypropylene is
employed as transvaginal mesh, as well as in surgeries to correct hernias and
pelvic organ prolapse.
Mobility aids is expected to be the fastest-growing segment in 2021.
The application includes medical components, medical device packaging,
orthopedic soft goods, mobility aids, and others. The mobility aids segment is
expected to witness the highest CAGR during the forecast period. As the global
geriatric population rises, plastics will increasingly be used in the
development of mobility aids. The market is anticipated to be further driven by
technological developments and increased healthcare spending. This is
anticipated to raise demand for plastics like acrylonitrile butadiene styrene
(ABS), PEEK, and polycarbonate on a global scale (PC). Due to its lightweight
nature, plastics are predicted to replace metal in a variety of medical
applications in addition to contributing to the spike in product demand for
mobility aids including wheelchairs, drinking aids, and bath seats.
Regional
Analysis
The regional analysis provides a detailed perception of the key
regions and the countries. Some of the key countries analyzed for the Medical
Plastic include US, Canada, Mexico, Germany, France, U.K., Italy, Spain,
Russia, China, Japan, India, Brazil, Peru, UAE, South Africa and Saudi Arabia.
●
North America region witnessed a major share.
The growing older population in the US and the rising need for home healthcare
services are the main factors driving the market for medical plastics in North
America. The local pharmaceutical industry has been significantly boosted by
this strategy, and as a result, product demand is anticipated to increase in
the forecast years. The regional market is also anticipated to be driven by
increasing product demand for pharmaceutical packaging applications and the swift
expansion of the pharmaceutical industries in Mexico and Canada. New
pharmaceutical manufacturing facilities have been developed in Mexico by big
corporations like Takeda and Astellas as a result of the removal of harsh rules
by the Mexican government that had previously limited the formation of new
manufacturing units.
Country Analysis
Germany's Medical Plastic market size was valued at USD 4.23
billion in 2021 and is expected to reach USD 7.37 billion by 2029, at a CAGR of
7.2% from 2022 to 2029. One of the key elements fueling
the expansion of medical plastics in the region is the rising need for home
healthcare in Germany due to the country's aging geriatric population.
Additionally, it is predicted that the market would rise during the forecast
period due to the enforcement and upgrading of various infection prevention
standards along with an increase in the number of surgical, inpatient, and
outpatient operations.
● China
China Medical Plastic’s market
size was valued at USD 3 billion in 2021 and is expected to reach USD 5 billion
by 2029, at a CAGR of 6.6% from 2022 to 2029. In the
forecast years, China's population is expected to grow. Diseases and illnesses
are rapidly spreading through a variety of media due to the growing population.
Also, the growing elderly population fosters the growth of the healthcare
industry. Additionally, medical plastics are used in prostheses, which provide
physically challenged persons with a life-altering answer. Each of these
elements has an impact on the local market.
● India
India's Medical Plastic market
size was valued at USD 2.70 billion in 2021 and is expected to reach USD 4.30
billion by 2029, at a CAGR of 6% from 2022 to 2029.
The market in India is being driven by a number of reasons, including as the
expanding elderly population, unified government policies, and the rising
incidence and prevalence of chronic diseases. India's medical device industry
ranked fourth globally in 2019, according to the India Brand Equity Foundation
(IBEF). Additionally, the country's expanding medical tourism industry
contributes significantly to market expansion.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as ICT,
healthcare, chemical & materials, semiconductors, automobiles, etc.
However, several companies operating in the medical plastics sector have seen
increased revenue due to the significant requirement for medical kits.
Furthermore, the growth of this market is mainly driven owing to the
increasing research and development in the healthcare sector.
Buy Now Full Report @ https://greyviews.com/checkout/175/single_user_license
Contact Us:
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: sales@greyviews.com
Contact Us: https://greyviews.com/contact-us/
Comments
Post a Comment